Literature DB >> 15914656

Cardiac performance in the zebrafish breakdance mutant.

Renate Kopp1, Thorsten Schwerte, Bernd Pelster.   

Abstract

In the Tubingen screen a breakdance mutant of zebrafish (bre) was described as an arrhythmia, in which the ventricle beats only with every second atrial contraction (2:1 rhythm). Surprisingly, a careful analysis of the effect of the breakdance mutation on cardiac performance of the zebrafish during development between 3 d.p.f. and 14 d.p.f revealed that homozygous bre mutants did not always show the 2:1 rhythm. Cardiac activity was continuously recorded for a period of 20 min in each larva, and during this period we observed that heart rate randomly switched between the 2:1 rhythm and a 1:1 rhythm. Furthermore, at 28 degrees C and at 31 degrees C the expression of the 2:1 rhythm decreased with development. At 31 degrees C this was in part due to a significantly reduced survival rate of mutants beyond 4 d.p.f. Besides development, temperature had a marked effect on the expression of the 2:1 rhythm, and during the first days of development the expression of the 2:1 rhythm was significantly higher at elevated incubation temperatures. By contrast, in the 2:1 beating heart ventricular contraction rate was about 80 beats min(-1) throughout development irrespective of the temperature, and even in the 1:1 rhythm mutants showed a significant bradycardia at all three temperatures (25 degrees C, 28 degrees C or 31 degrees C). Compared to wild-type animals, cardiac output was significantly lower in bre mutants. Pressure traces recorded in the ventricle of mutants revealed a prolonged relaxation phase, indicating that the second pacemaker current could not be conveyed to the ventricle (AV-block). This phenotype is comparable to the human Long QT Syndrome, an arrhythmia caused by a modification of an ion channel involved in cardiac repolarization. The bradycardia and the modified temperature sensitivity of heart rate suggested that the activity of the pacemaker cells was also affected by this mutation.

Entities:  

Mesh:

Year:  2005        PMID: 15914656     DOI: 10.1242/jeb.01620

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  26 in total

1.  Sensitivity to dioxin decreases as zebrafish mature.

Authors:  Kevin A Lanham; Richard E Peterson; Warren Heideman
Journal:  Toxicol Sci       Date:  2012-03-08       Impact factor: 4.849

Review 2.  Optical mapping in the developing zebrafish heart.

Authors:  M Khaled Sabeh; Hussein Kekhia; Calum A Macrae
Journal:  Pediatr Cardiol       Date:  2012-03-30       Impact factor: 1.655

3.  Zebrafish as a model for cardiovascular development and disease.

Authors:  Catherine T Nguyen; Qing Lu; Yibin Wang; Jau-Nian Chen
Journal:  Drug Discov Today Dis Models       Date:  2008

4.  Deep and fast live imaging with two-photon scanned light-sheet microscopy.

Authors:  Thai V Truong; Willy Supatto; David S Koos; John M Choi; Scott E Fraser
Journal:  Nat Methods       Date:  2011-07-17       Impact factor: 28.547

Review 5.  Small molecule screening in zebrafish.

Authors:  David S Peal; Randall T Peterson; David Milan
Journal:  J Cardiovasc Transl Res       Date:  2010-08-03       Impact factor: 4.132

Review 6.  Uncovering the molecular and cellular mechanisms of heart development using the zebrafish.

Authors:  David Staudt; Didier Stainier
Journal:  Annu Rev Genet       Date:  2012-09-04       Impact factor: 16.830

7.  The Popeye domain containing 2 (popdc2) gene in zebrafish is required for heart and skeletal muscle development.

Authors:  Bettina C Kirchmaier; Kar Lai Poon; Thorsten Schwerte; Jan Huisken; Christoph Winkler; Benno Jungblut; Didier Y Stainier; Thomas Brand
Journal:  Dev Biol       Date:  2012-01-28       Impact factor: 3.582

8.  3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart.

Authors:  Vytautas Zickus; Jonathan M Taylor
Journal:  Biomed Opt Express       Date:  2018-04-27       Impact factor: 3.732

9.  Zebrafish model for human long QT syndrome.

Authors:  Rima Arnaout; Tania Ferrer; Jan Huisken; Kenneth Spitzer; Didier Y R Stainier; Martin Tristani-Firouzi; Neil C Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

10.  An in vivo cardiac assay to determine the functional consequences of putative long QT syndrome mutations.

Authors:  Chuanchau J Jou; Spencer M Barnett; Jian-Tao Bian; H Cindy Weng; Xiaoming Sheng; Martin Tristani-Firouzi
Journal:  Circ Res       Date:  2013-01-09       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.